Annual Operating Profit
$3.36 B
+$170.00 M+5.32%
December 31, 2024
Summary
- As of February 22, 2025, TEVA annual operating income is $3.36 billion, with the most recent change of +$170.00 million (+5.32%) on December 31, 2024.
- During the last 3 years, TEVA annual operating profit has risen by +$265.00 million (+8.55%).
- TEVA annual operating profit is now -32.63% below its all-time high of $4.99 billion, reached on December 31, 2015.
Performance
TEVA Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Profit
$920.00 M
-$64.00 M-6.50%
December 31, 2024
Summary
- As of February 22, 2025, TEVA quarterly operating income is $920.00 million, with the most recent change of -$64.00 million (-6.50%) on December 31, 2024.
- Over the past year, TEVA quarterly operating profit has increased by +$278.00 million (+43.30%).
- TEVA quarterly operating profit is now -30.88% below its all-time high of $1.33 billion, reached on June 30, 2015.
Performance
TEVA Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Operating Profit
$3.36 B
-$366.00 M-9.82%
December 31, 2024
Summary
- As of February 22, 2025, TEVA TTM operating income is $3.36 billion, with the most recent change of -$366.00 million (-9.82%) on December 31, 2024.
- Over the past year, TEVA TTM operating profit has increased by +$34.00 million (+1.02%).
- TEVA TTM operating profit is now -34.13% below its all-time high of $5.10 billion, reached on September 30, 2015.
Performance
TEVA TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Profit Formula
Operating Profit = Gross Profit − Operating Expenses
TEVA Operating Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +5.3% | +43.3% | +1.0% |
| 3 y3 years | +8.6% | +32.8% | +15.4% |
| 5 y5 years | +23.6% | +28.7% | +10.0% |
TEVA Operating Profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +25.1% | -28.5% | +81.1% | -9.8% | +36.5% |
| 5 y | 5-year | at high | +25.1% | -28.5% | +81.1% | -9.8% | +36.5% |
| alltime | all time | -32.6% | >+9999.0% | -30.9% | +231.8% | -34.1% | +708.7% |
Teva Pharmaceutical Industries Limited Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $3.36 B(+5.3%) | $920.00 M(-6.5%) | $3.36 B(-9.8%) |
| Sep 2024 | - | $984.00 M(+20.6%) | $3.73 B(+6.6%) |
| Jun 2024 | - | $816.00 M(+27.1%) | $3.50 B(+5.1%) |
| Mar 2024 | - | $642.00 M(-50.1%) | $3.33 B(+4.2%) |
| Dec 2023 | $3.19 B(+18.7%) | $1.29 B(+70.6%) | $3.19 B(+25.6%) |
| Sep 2023 | - | $754.00 M(+16.7%) | $2.54 B(+3.2%) |
| Jun 2023 | - | $646.00 M(+27.2%) | $2.46 B(-1.9%) |
| Mar 2023 | - | $508.00 M(-20.0%) | $2.51 B(-6.7%) |
| Dec 2022 | $2.69 B(-13.2%) | $635.00 M(-5.8%) | $2.69 B(-6.6%) |
| Sep 2022 | - | $674.00 M(-2.7%) | $2.88 B(-1.2%) |
| Jun 2022 | - | $693.00 M(+0.9%) | $2.91 B(-3.9%) |
| Mar 2022 | - | $687.00 M(-16.7%) | $3.03 B(-2.2%) |
| Dec 2021 | $3.10 B(+1.3%) | $825.00 M(+16.4%) | $3.10 B(+3.7%) |
| Sep 2021 | - | $709.00 M(-12.6%) | $2.99 B(-0.3%) |
| Jun 2021 | - | $811.00 M(+7.6%) | $3.00 B(+4.4%) |
| Mar 2021 | - | $754.00 M(+5.5%) | $2.87 B(-6.0%) |
| Dec 2020 | $3.06 B(+12.4%) | $715.00 M(-0.4%) | $3.06 B(+1.4%) |
| Sep 2020 | - | $718.00 M(+4.7%) | $3.01 B(-0.2%) |
| Jun 2020 | - | $686.00 M(-26.9%) | $3.02 B(+0.7%) |
| Mar 2020 | - | $938.00 M(+39.6%) | $3.00 B(+10.2%) |
| Dec 2019 | $2.72 B(-5.2%) | $672.00 M(-7.2%) | $2.72 B(+5.3%) |
| Sep 2019 | - | $724.00 M(+9.0%) | $2.58 B(+2.6%) |
| Jun 2019 | - | $664.00 M(+0.5%) | $2.52 B(-3.1%) |
| Mar 2019 | - | $661.00 M(+23.6%) | $2.60 B(-9.4%) |
| Dec 2018 | $2.87 B(-28.1%) | $535.00 M(-18.7%) | $2.87 B(-12.0%) |
| Sep 2018 | - | $658.00 M(-11.7%) | $3.26 B(-7.0%) |
| Jun 2018 | - | $745.00 M(-20.0%) | $3.50 B(-8.7%) |
| Mar 2018 | - | $931.00 M(+0.6%) | $3.84 B(-3.8%) |
| Dec 2017 | $3.99 B(-13.3%) | $925.00 M(+2.3%) | $3.99 B(-6.8%) |
| Sep 2017 | - | $904.00 M(-16.2%) | $4.28 B(+0.4%) |
| Jun 2017 | - | $1.08 B(-0.4%) | $4.27 B(-3.6%) |
| Mar 2017 | - | $1.08 B(-11.0%) | $4.43 B(-3.8%) |
| Dec 2016 | $4.60 B(-7.8%) | $1.22 B(+37.0%) | $4.60 B(+3.2%) |
| Sep 2016 | - | $888.00 M(-28.3%) | $4.46 B(-8.7%) |
| Jun 2016 | - | $1.24 B(-1.6%) | $4.88 B(-1.8%) |
| Mar 2016 | - | $1.26 B(+17.3%) | $4.98 B(-0.3%) |
| Dec 2015 | $4.99 B(+11.2%) | $1.07 B(-18.3%) | $4.99 B(-2.2%) |
| Sep 2015 | - | $1.31 B(-1.3%) | $5.10 B(+3.2%) |
| Jun 2015 | - | $1.33 B(+4.4%) | $4.94 B(+5.0%) |
| Mar 2015 | - | $1.27 B(+7.7%) | $4.71 B(+4.8%) |
| Dec 2014 | $4.49 B(+13.4%) | $1.18 B(+2.6%) | $4.49 B(+3.4%) |
| Sep 2014 | - | $1.15 B(+5.5%) | $4.34 B(+3.3%) |
| Jun 2014 | - | $1.09 B(+3.4%) | $4.20 B(+3.5%) |
| Mar 2014 | - | $1.06 B(+2.2%) | $4.06 B(+2.5%) |
| Dec 2013 | $3.96 B(-5.2%) | $1.03 B(+2.1%) | $3.96 B(+1.7%) |
| Sep 2013 | - | $1.01 B(+6.4%) | $3.90 B(-1.4%) |
| Jun 2013 | - | $953.00 M(-0.6%) | $3.95 B(-2.7%) |
| Mar 2013 | - | $959.00 M(-1.0%) | $4.06 B(-2.8%) |
| Dec 2012 | $4.18 B(+4.2%) | $969.00 M(-9.5%) | $4.18 B(-4.3%) |
| Sep 2012 | - | $1.07 B(+0.8%) | $4.37 B(-0.3%) |
| Jun 2012 | - | $1.06 B(-1.4%) | $4.38 B(+4.6%) |
| Mar 2012 | - | $1.08 B(-7.1%) | $4.19 B(+4.5%) |
| Dec 2011 | $4.01 B(-6.3%) | $1.16 B(+6.7%) | $4.01 B(+1.6%) |
| Sep 2011 | - | $1.09 B(+25.0%) | $3.95 B(-3.8%) |
| Jun 2011 | - | $869.00 M(-3.0%) | $4.10 B(-4.9%) |
| Mar 2011 | - | $896.00 M(-18.3%) | $4.31 B(+0.6%) |
| Dec 2010 | $4.28 B(+39.6%) | $1.10 B(-11.6%) | $4.29 B(+4.6%) |
| Sep 2010 | - | $1.24 B(+14.9%) | $4.10 B(+10.5%) |
| Jun 2010 | - | $1.08 B(+23.9%) | $3.71 B(+9.6%) |
| Mar 2010 | - | $872.00 M(-4.2%) | $3.39 B(+10.4%) |
| Dec 2009 | $3.07 B(+141.6%) | $910.00 M(+7.1%) | $3.07 B(+110.3%) |
| Sep 2009 | - | $850.00 M(+12.7%) | $1.46 B(+15.9%) |
| Jun 2009 | - | $754.00 M(+36.6%) | $1.26 B(+10.2%) |
| Mar 2009 | - | $552.00 M(-179.1%) | $1.14 B(-10.0%) |
| Dec 2008 | $1.27 B(-47.0%) | -$698.00 M(-207.4%) | $1.27 B(-51.7%) |
| Sep 2008 | - | $650.00 M(+1.9%) | $2.63 B(-0.0%) |
| Jun 2008 | - | $638.00 M(-6.0%) | $2.63 B(+0.0%) |
| Mar 2008 | - | $679.00 M(+2.7%) | $2.63 B(+9.7%) |
| Dec 2007 | $2.40 B(+14.3%) | $661.00 M(+1.5%) | $2.40 B(+11.0%) |
| Sep 2007 | - | $651.00 M(+2.2%) | $2.16 B(-3.3%) |
| Jun 2007 | - | $637.00 M(+42.8%) | $2.23 B(-1.7%) |
| Mar 2007 | - | $446.00 M(+5.5%) | $2.27 B(+6.6%) |
| Dec 2006 | $2.10 B(+59.8%) | $422.80 M(-41.6%) | $2.13 B(+3.0%) |
| Sep 2006 | - | $723.60 M(+7.2%) | $2.07 B(+24.9%) |
| Jun 2006 | - | $675.20 M(+120.7%) | $1.65 B(+28.5%) |
| Mar 2006 | - | $306.00 M(-15.1%) | $1.29 B(-1.9%) |
| Dec 2005 | $1.31 B | $360.30 M(+15.4%) | $1.31 B(+1.9%) |
| Sep 2005 | - | $312.20 M(+1.2%) | $1.29 B(-0.4%) |
| Jun 2005 | - | $308.60 M(-6.7%) | $1.29 B(+0.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2005 | - | $330.90 M(-1.5%) | $1.28 B(+9.1%) |
| Dec 2004 | $1.18 B(+32.8%) | $336.00 M(+5.8%) | $1.18 B(+10.3%) |
| Sep 2004 | - | $317.70 M(+6.9%) | $1.07 B(+12.8%) |
| Jun 2004 | - | $297.10 M(+32.5%) | $944.90 M(+1.6%) |
| Mar 2004 | - | $224.20 M(-1.0%) | $929.70 M(+5.1%) |
| Dec 2003 | $884.80 M(+68.9%) | $226.50 M(+14.9%) | $884.80 M(+5.2%) |
| Sep 2003 | - | $197.10 M(-30.1%) | $840.90 M(+9.9%) |
| Jun 2003 | - | $281.90 M(+57.2%) | $765.40 M(+28.6%) |
| Mar 2003 | - | $179.30 M(-1.8%) | $595.10 M(+13.6%) |
| Dec 2002 | $524.00 M(+39.2%) | $182.60 M(+50.2%) | $524.00 M(+15.6%) |
| Sep 2002 | - | $121.60 M(+9.0%) | $453.16 M(+5.2%) |
| Jun 2002 | - | $111.60 M(+3.1%) | $430.56 M(+6.1%) |
| Mar 2002 | - | $108.20 M(-3.2%) | $405.81 M(+7.8%) |
| Dec 2001 | $376.46 M(+0.3%) | $111.76 M(+12.9%) | $376.51 M(-14.6%) |
| Sep 2001 | - | $99.00 M(+14.0%) | $440.71 M(+5.9%) |
| Jun 2001 | - | $86.85 M(+10.1%) | $416.13 M(+4.5%) |
| Mar 2001 | - | $78.90 M(-55.2%) | $398.12 M(+6.1%) |
| Dec 2000 | $375.21 M(+40.3%) | $175.95 M(+136.4%) | $375.21 M(+13.9%) |
| Sep 2000 | - | $74.42 M(+8.1%) | $329.32 M(+7.4%) |
| Jun 2000 | - | $68.84 M(+22.9%) | $306.55 M(+8.5%) |
| Mar 2000 | - | $56.00 M(-56.9%) | $282.45 M(+5.6%) |
| Dec 1999 | $267.47 M(+31.3%) | $130.07 M(+151.9%) | $267.37 M(+10.5%) |
| Sep 1999 | - | $51.64 M(+15.4%) | $241.94 M(+5.2%) |
| Jun 1999 | - | $44.74 M(+9.3%) | $229.99 M(+10.1%) |
| Mar 1999 | - | $40.92 M(-60.9%) | $208.85 M(+2.6%) |
| Dec 1998 | $203.73 M(+17.2%) | $104.63 M(+163.6%) | $203.53 M(-136.9%) |
| Sep 1998 | - | $39.70 M(+68.2%) | -$552.30 M(+80.9%) |
| Jun 1998 | - | $23.60 M(-33.7%) | -$305.30 M(+424.5%) |
| Mar 1998 | - | $35.60 M(-105.5%) | -$58.20 M(-133.5%) |
| Dec 1997 | $173.80 M(+34.4%) | -$651.20 M(-327.1%) | $173.80 M(-37.5%) |
| Sep 1997 | - | $286.70 M(+5.9%) | $278.20 M(+22.0%) |
| Jun 1997 | - | $270.70 M(+1.2%) | $228.10 M(+9.9%) |
| Mar 1997 | - | $267.60 M(-148.9%) | $207.60 M(+60.6%) |
| Dec 1996 | $129.30 M(+24.1%) | -$546.80 M(-331.1%) | $129.30 M(-57.7%) |
| Sep 1996 | - | $236.60 M(-5.4%) | $305.50 M(+30.4%) |
| Jun 1996 | - | $250.20 M(+32.2%) | $234.20 M(+66.3%) |
| Mar 1996 | - | $189.30 M(-151.1%) | $140.80 M(+35.1%) |
| Dec 1995 | $104.20 M(+0.7%) | -$370.60 M(-324.2%) | $104.20 M(-31.1%) |
| Sep 1995 | - | $165.30 M(+5.4%) | $151.20 M(+16.8%) |
| Jun 1995 | - | $156.80 M(+2.7%) | $129.40 M(+8.3%) |
| Mar 1995 | - | $152.70 M(-147.2%) | $119.50 M(+15.5%) |
| Dec 1994 | $103.50 M(+17.6%) | -$323.60 M(-325.5%) | $103.50 M(-28.3%) |
| Sep 1994 | - | $143.50 M(-2.3%) | $144.40 M(+12.7%) |
| Jun 1994 | - | $146.90 M(+7.5%) | $128.10 M(+20.6%) |
| Mar 1994 | - | $136.70 M(-148.4%) | $106.20 M(+20.8%) |
| Dec 1993 | $88.00 M(+60.9%) | -$282.70 M(-322.2%) | $87.90 M(-41.6%) |
| Sep 1993 | - | $127.20 M(+1.8%) | $150.50 M(+29.4%) |
| Jun 1993 | - | $125.00 M(+5.6%) | $116.30 M(+38.0%) |
| Mar 1993 | - | $118.40 M(-153.8%) | $84.30 M(+43.4%) |
| Dec 1992 | $54.70 M(+5.0%) | -$220.10 M(-336.7%) | $58.80 M(-32.1%) |
| Sep 1992 | - | $93.00 M(0.0%) | $86.60 M(+19.8%) |
| Jun 1992 | - | $93.00 M(+0.1%) | $72.30 M(+26.6%) |
| Mar 1992 | - | $92.90 M(-148.3%) | $57.10 M(+10.9%) |
| Dec 1991 | $52.10 M(+29.3%) | -$192.30 M(-344.3%) | $51.50 M(-45.8%) |
| Sep 1991 | - | $78.70 M(+1.2%) | $95.00 M(+20.4%) |
| Jun 1991 | - | $77.80 M(-10.9%) | $78.90 M(+11.6%) |
| Mar 1991 | - | $87.30 M(-158.7%) | $70.70 M(+44.0%) |
| Dec 1990 | $40.30 M(-8.8%) | -$148.80 M(-337.7%) | $49.10 M(+6.0%) |
| Sep 1990 | - | $62.60 M(-10.1%) | $46.30 M(-2.5%) |
| Jun 1990 | - | $69.60 M(+5.9%) | $47.50 M(+1.7%) |
| Mar 1990 | - | $65.70 M(-143.3%) | $46.70 M(-5.1%) |
| Dec 1989 | $44.20 M(+96.4%) | -$151.60 M(-337.6%) | $49.20 M(-37.4%) |
| Sep 1989 | - | $63.80 M(-7.3%) | $78.60 M(+28.0%) |
| Jun 1989 | - | $68.80 M(+0.9%) | $61.40 M(+43.8%) |
| Mar 1989 | - | $68.20 M(-155.8%) | $42.70 M(+74.3%) |
| Dec 1988 | $22.50 M(+16.6%) | -$122.20 M(-362.2%) | $24.50 M(-83.3%) |
| Sep 1988 | - | $46.60 M(-7.0%) | $146.70 M(+14.1%) |
| Jun 1988 | - | $50.10 M(+0.2%) | $128.60 M(+22.6%) |
| Mar 1988 | - | $50.00 M(+75.4%) | $104.90 M(+2284.1%) |
| Sep 1987 | - | $28.50 M(+8.0%) | $4.40 M(-59.3%) |
| Jun 1987 | - | $26.40 M(-130.9%) | $10.80 M(-44.0%) |
| Mar 1987 | $19.30 M(+62.2%) | -$85.40 M(-344.7%) | $19.30 M(-60.0%) |
| Dec 1986 | - | $34.90 M(0.0%) | $48.20 M(+33.5%) |
| Sep 1986 | - | $34.90 M(0.0%) | $36.10 M(+50.4%) |
| Jun 1986 | - | $34.90 M(-161.8%) | $24.00 M(+101.7%) |
| Mar 1986 | $11.90 M | -$56.50 M(-347.8%) | $11.90 M(-82.6%) |
| Dec 1985 | - | $22.80 M(0.0%) | $68.40 M(+50.0%) |
| Sep 1985 | - | $22.80 M(0.0%) | $45.60 M(+100.0%) |
| Jun 1985 | - | $22.80 M | $22.80 M |
FAQ
- What is Teva Pharmaceutical Industries Limited annual operating income?
- What is the all time high annual operating profit for Teva Pharmaceutical Industries Limited?
- What is Teva Pharmaceutical Industries Limited annual operating profit year-on-year change?
- What is Teva Pharmaceutical Industries Limited quarterly operating income?
- What is the all time high quarterly operating profit for Teva Pharmaceutical Industries Limited?
- What is Teva Pharmaceutical Industries Limited quarterly operating profit year-on-year change?
- What is Teva Pharmaceutical Industries Limited TTM operating income?
- What is the all time high TTM operating profit for Teva Pharmaceutical Industries Limited?
- What is Teva Pharmaceutical Industries Limited TTM operating profit year-on-year change?
What is Teva Pharmaceutical Industries Limited annual operating income?
The current annual operating profit of TEVA is $3.36 B
What is the all time high annual operating profit for Teva Pharmaceutical Industries Limited?
Teva Pharmaceutical Industries Limited all-time high annual operating income is $4.99 B
What is Teva Pharmaceutical Industries Limited annual operating profit year-on-year change?
Over the past year, TEVA annual operating income has changed by +$170.00 M (+5.32%)
What is Teva Pharmaceutical Industries Limited quarterly operating income?
The current quarterly operating profit of TEVA is $920.00 M
What is the all time high quarterly operating profit for Teva Pharmaceutical Industries Limited?
Teva Pharmaceutical Industries Limited all-time high quarterly operating income is $1.33 B
What is Teva Pharmaceutical Industries Limited quarterly operating profit year-on-year change?
Over the past year, TEVA quarterly operating income has changed by +$278.00 M (+43.30%)
What is Teva Pharmaceutical Industries Limited TTM operating income?
The current TTM operating profit of TEVA is $3.36 B
What is the all time high TTM operating profit for Teva Pharmaceutical Industries Limited?
Teva Pharmaceutical Industries Limited all-time high TTM operating income is $5.10 B
What is Teva Pharmaceutical Industries Limited TTM operating profit year-on-year change?
Over the past year, TEVA TTM operating income has changed by +$34.00 M (+1.02%)